pharma · Monocarboxylate Transporter 8 (MCT8) deficiency
Rare Thyroid Therapeutics
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Stockholm, SE
- Founded
- 2017
- Employees
- 1
- Programs
- 2
- Drugs
- 6
- Patents
- 0
Rare Thyroid Therapeutics patents
0 pharmaceutical patents indexed for Rare Thyroid Therapeutics. 0 expire within 24 months.
Rare Thyroid Therapeutics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Rare Thyroid Therapeutics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Rare Thyroid Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.